Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Sarepta Therapeutics Inc New (SRPT)

2014-10-21@04:39:00 ET
Research and Markets: Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical (BIZ)

2014-10-21@04:14:36 ET
Global Potential Analysis of Ebola Drug and Vaccines Market 2014-2020: Leading Companies are Tekmira, BioCryst, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical (MTO)

2014-10-21@04:09:06 ET
Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Insitutions (MTO)

2014-10-21@01:51:01 ET
Sarepta Therapeutics Releases Publication of Ebola and Marburg Phase I Clinical Study Results (CLM)

2014-10-17@13:49:55 ET
Sector Update: Strong Advance for Health Care Sector; Sarepta Therapeutics Up After Positive Results for Possible Ebola Treatment (MID)

2014-10-17@13:47:22 ET
Sector Update: Health Care (MID)

2014-10-08@08:30:36 ET
Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society (BIZ)

2014-10-03@09:31:00 ET
Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver (PRN)

2014-10-03@01:10:25 ET
Sarepta Therapeutics Presents Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate (CLM)

2014-10-01@07:11:57 ET
Sarepta announces encouraging results from Phase I influenza study (DTM)

2014-09-30@07:30:18 ET
Sarepta Therapeutics Announces Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate (BIZ)

2014-09-30@01:36:23 ET
Sarepta Therapeutics to Take Part in Roundtable (CLM)

2014-09-29@01:47:05 ET
Sarepta Therapeutics to Take Part in Roundtable (CLM)

2014-09-24@17:25:02 ET
Sarepta Therapeutics to Present at Leerink Partners Rare Disease Roundtable (BIZ)

2014-09-22@21:19:22 ET
Sarepta Therapeutics, Inc.Corporate Event Announcement Notice (WSH)

2014-07-23@00:54:37 ET
Sarepta Therapeutics Rolls Out Data from Study 202 (CLM)

2014-07-18@18:40:57 ET
Great Way to Close the Week (ETF)

2014-07-17@09:30:00 ET
The Zacks Analyst Blog Highlights:AbbVie, Shire, Gilead Sciences, Sarepta Therapeutics and Celgene (PRN)

2014-07-16@10:51:40 ET
Sarepta announces encouraging data from Phase IIb muscular dystrophy study (DTM)

2014-07-16@09:31:00 ET
Critical Alerts For General Electric, Sarepta Therapeutics, iRobot, Goldman Sachs, and Baidu Released By InvestorsObserver (PRN)